---
schema_version: "secwatch.filing_event.v1"
accession: "0001013762-24-000518"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2024-07-22T23:59:59+00:00"
generated_at: "2026-05-31T18:30:32.226349+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma raises $2.1M in registered direct offering of 763,638 shares at $2.75

## Summary
- Gross proceeds ~$2.1M from sale of 763,638 common shares at $2.75 each.
- Concurrent private placement of warrants to buy 763,638 shares at $2.75, exercisable for 5 years.
- H.C. Wainwright acted as exclusive placement agent; fees include 7.5% cash and 57,273 placement agent warrants.
- Net proceeds to be used for working capital and general corporate purposes.
- Offering closed on July 22, 2024.

## SEC filing metadata
- accession: 0001013762-24-000518
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2024-07-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000101376224000518/0001013762-24-000518-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000101376224000518/ea0209765-8k_silopharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001013762-24-000518
- JSON: https://secwatch.observer/filing/0001013762-24-000518.json
- Plain text: https://secwatch.observer/filing/0001013762-24-000518.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.